Plus   Neg

Pebblebrook Hotel Trust Adjusts 2019 Outlook - Quick Facts

Pebblebrook Hotel Trust (PEB) announced, for fiscal 2019, the company now projects adjusted FFO per share in a range of $2.57 to $2.60 (midpoint down $0.06). Same-Property RevPAR growth rate is anticipated to be in a range of 0.6% to 1.2% (midpoint down 60 bps).

For the third-quarter, adjusted FFO per share was $0.77, up 4.1 percent from last year. Same-Property total RevPAR declined 1.0 percent from prior year.

"During the third quarter, our overall performance versus our expectations was impacted by weaker performance in San Diego, Los Angeles, San Francisco and Washington, D.C.," said Jon Bortz, CEO of Pebblebrook Hotel Trust.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) has gone ahead with the approval of antiviral drug remdesivir as first treatment for COVID-19, notwithstanding last week's findings by the World Health Organization (WHO) that the drug is not effective for COVID-19 treatment. Thursday, Gilead Sciences announced that the FDA approved remdesivir, sold under the brand name Veklury. Integrated payments firm American Express Co. (AXP) reported Friday that net income for the third quarter declined to $1.1 billion or $1.30 per share from $1.8 billion or $2.08 per share in the prior-year quarter. Consolidated total revenues, net of interest expense, also decreased 20 percent to $8.8... The Federal Trade Commission or FTC has launched a new fraud reporting platform, using which, consumers can easily report fraud and all other consumer issues directly to the regulator. In a statement, the FTC said its new website, ReportFraud.ftc.gov, will provide a streamlined and user-friendly way to submit reports about scams, frauds, and bad business practices.
Follow RTT